 Klane White
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Achondroplasia | 9 | 2023 | 10 | 3.050 |
Why?
| | Scoliosis | 18 | 2024 | 223 | 2.980 |
Why?
| | Mucopolysaccharidoses | 8 | 2023 | 12 | 2.290 |
Why?
| | Spine | 11 | 2024 | 182 | 1.840 |
Why?
| | Orthopedic Procedures | 8 | 2021 | 242 | 1.570 |
Why?
| | Foramen Magnum | 3 | 2016 | 10 | 1.390 |
Why?
| | Osteochondrodysplasias | 3 | 2021 | 20 | 1.320 |
Why?
| | Thoracic Vertebrae | 5 | 2024 | 79 | 1.290 |
Why?
| | Osteotomy | 3 | 2024 | 127 | 1.230 |
Why?
| | Cervical Vertebrae | 5 | 2021 | 157 | 1.110 |
Why?
| | Bone Diseases, Developmental | 5 | 2024 | 16 | 1.020 |
Why?
| | Sleep Apnea Syndromes | 3 | 2016 | 97 | 0.950 |
Why?
| | Osteogenesis, Distraction | 2 | 2024 | 25 | 0.890 |
Why?
| | Acrocephalosyndactylia | 1 | 2024 | 12 | 0.870 |
Why?
| | Hernia, Diaphragmatic | 1 | 2024 | 67 | 0.850 |
Why?
| | Bone and Bones | 2 | 2019 | 313 | 0.840 |
Why?
| | Mucopolysaccharidosis IV | 3 | 2014 | 6 | 0.810 |
Why?
| | Constriction, Pathologic | 5 | 2016 | 248 | 0.800 |
Why?
| | Hip Dislocation, Congenital | 3 | 2013 | 39 | 0.780 |
Why?
| | Child | 48 | 2025 | 22537 | 0.780 |
Why?
| | Disease Management | 3 | 2019 | 643 | 0.770 |
Why?
| | Abnormalities, Multiple | 1 | 2024 | 197 | 0.760 |
Why?
| | Kyphosis | 4 | 2019 | 37 | 0.720 |
Why?
| | Mucopolysaccharidosis VI | 3 | 2023 | 5 | 0.710 |
Why?
| | Spinal Fusion | 8 | 2022 | 260 | 0.670 |
Why?
| | Vertebral Artery | 1 | 2021 | 26 | 0.660 |
Why?
| | Practice Guidelines as Topic | 5 | 2019 | 1559 | 0.660 |
Why?
| | Child, Preschool | 26 | 2025 | 11774 | 0.640 |
Why?
| | Carpal Tunnel Syndrome | 2 | 2017 | 30 | 0.610 |
Why?
| | Spinal Cord Injuries | 3 | 2021 | 240 | 0.610 |
Why?
| | Natriuretic Peptide, C-Type | 4 | 2023 | 5 | 0.590 |
Why?
| | Turner Syndrome | 1 | 2019 | 63 | 0.580 |
Why?
| | Length of Stay | 3 | 2022 | 1335 | 0.570 |
Why?
| | Mucopolysaccharidosis I | 4 | 2023 | 10 | 0.560 |
Why?
| | Inpatients | 1 | 2022 | 542 | 0.540 |
Why?
| | Ribs | 3 | 2018 | 35 | 0.510 |
Why?
| | Rare Diseases | 1 | 2017 | 113 | 0.500 |
Why?
| | Humans | 74 | 2025 | 144261 | 0.480 |
Why?
| | Titanium | 3 | 2018 | 81 | 0.480 |
Why?
| | Coxa Vara | 1 | 2015 | 1 | 0.460 |
Why?
| | Osteogenesis Imperfecta | 2 | 2024 | 14 | 0.460 |
Why?
| | Retrospective Studies | 27 | 2024 | 17009 | 0.450 |
Why?
| | Bone Diseases | 2 | 2016 | 61 | 0.450 |
Why?
| | Perioperative Care | 1 | 2017 | 230 | 0.440 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2014 | 8 | 0.430 |
Why?
| | Thoracic Surgical Procedures | 2 | 2016 | 94 | 0.410 |
Why?
| | Bone Remodeling | 1 | 2014 | 71 | 0.400 |
Why?
| | Polysomnography | 3 | 2024 | 234 | 0.400 |
Why?
| | Diphosphonates | 1 | 2014 | 68 | 0.390 |
Why?
| | Bone Density Conservation Agents | 1 | 2014 | 81 | 0.390 |
Why?
| | Adolescent | 26 | 2025 | 22281 | 0.390 |
Why?
| | Radiography | 7 | 2018 | 842 | 0.370 |
Why?
| | Neonatal Screening | 1 | 2013 | 178 | 0.350 |
Why?
| | Female | 42 | 2025 | 77976 | 0.350 |
Why?
| | Mucopolysaccharidosis III | 1 | 2011 | 1 | 0.350 |
Why?
| | Male | 42 | 2025 | 72035 | 0.350 |
Why?
| | Postoperative Complications | 5 | 2024 | 2916 | 0.330 |
Why?
| | Quality of Life | 6 | 2024 | 3166 | 0.330 |
Why?
| | Age of Onset | 6 | 2024 | 536 | 0.310 |
Why?
| | Musculoskeletal Diseases | 1 | 2011 | 88 | 0.310 |
Why?
| | Infant | 12 | 2024 | 10022 | 0.310 |
Why?
| | Contracture | 2 | 2023 | 22 | 0.300 |
Why?
| | Femur Head | 1 | 2010 | 39 | 0.300 |
Why?
| | Lumbar Vertebrae | 3 | 2008 | 252 | 0.300 |
Why?
| | Quadriplegia | 1 | 2009 | 14 | 0.290 |
Why?
| | Musculoskeletal Abnormalities | 2 | 2019 | 14 | 0.290 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 338 | 0.280 |
Why?
| | Spinal Cord Compression | 3 | 2013 | 22 | 0.280 |
Why?
| | Bone Screws | 2 | 2006 | 110 | 0.270 |
Why?
| | Lung | 1 | 2021 | 4108 | 0.260 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 6021 | 0.260 |
Why?
| | Prostheses and Implants | 2 | 2020 | 141 | 0.260 |
Why?
| | Reoperation | 2 | 2024 | 629 | 0.240 |
Why?
| | Lumbosacral Plexus | 1 | 2025 | 10 | 0.230 |
Why?
| | Athletic Injuries | 2 | 2003 | 569 | 0.230 |
Why?
| | Prosthesis Failure | 2 | 2020 | 125 | 0.230 |
Why?
| | Joint Prosthesis | 1 | 2005 | 22 | 0.230 |
Why?
| | Follow-Up Studies | 9 | 2024 | 5389 | 0.220 |
Why?
| | Osseointegration | 1 | 2005 | 60 | 0.220 |
Why?
| | Amides | 1 | 2025 | 101 | 0.220 |
Why?
| | Anesthetics, Local | 1 | 2025 | 100 | 0.220 |
Why?
| | Arthroplasty, Replacement | 1 | 2005 | 47 | 0.220 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2005 | 142 | 0.210 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2024 | 6 | 0.210 |
Why?
| | Hip Dislocation | 2 | 2016 | 53 | 0.210 |
Why?
| | Joint Instability | 3 | 2013 | 182 | 0.210 |
Why?
| | Prosthesis Design | 2 | 2020 | 354 | 0.210 |
Why?
| | Nerve Block | 1 | 2025 | 103 | 0.210 |
Why?
| | Mucopolysaccharidosis II | 1 | 2023 | 2 | 0.200 |
Why?
| | Patient Care Team | 2 | 2021 | 686 | 0.200 |
Why?
| | Basketball | 1 | 2003 | 17 | 0.190 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 54 | 0.190 |
Why?
| | Tracheostomy | 1 | 2024 | 142 | 0.190 |
Why?
| | Vital Capacity | 2 | 2021 | 290 | 0.190 |
Why?
| | Treatment Outcome | 12 | 2024 | 11643 | 0.190 |
Why?
| | Genu Valgum | 2 | 2013 | 2 | 0.190 |
Why?
| | Ilium | 1 | 2002 | 30 | 0.190 |
Why?
| | Soccer | 1 | 2003 | 38 | 0.190 |
Why?
| | Transforming Growth Factor beta | 1 | 2005 | 479 | 0.180 |
Why?
| | Joint Diseases | 1 | 2023 | 62 | 0.180 |
Why?
| | Infant, Newborn | 4 | 2024 | 6424 | 0.180 |
Why?
| | Adult | 14 | 2024 | 40262 | 0.180 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1367 | 0.180 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2022 | 79 | 0.180 |
Why?
| | Electromyography | 2 | 2005 | 415 | 0.170 |
Why?
| | Anterior Cruciate Ligament Injuries | 2 | 2005 | 216 | 0.170 |
Why?
| | Tomography, X-Ray Computed | 4 | 2021 | 2730 | 0.170 |
Why?
| | Bicarbonates | 1 | 2021 | 45 | 0.170 |
Why?
| | Connective Tissue Diseases | 1 | 2022 | 84 | 0.170 |
Why?
| | Genetic Testing | 1 | 2024 | 478 | 0.170 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2019 | 674 | 0.170 |
Why?
| | Risk Assessment | 2 | 2021 | 3637 | 0.170 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2021 | 32 | 0.160 |
Why?
| | Preoperative Period | 1 | 2021 | 148 | 0.160 |
Why?
| | Exostoses, Multiple Hereditary | 1 | 2020 | 5 | 0.160 |
Why?
| | Neck | 1 | 2021 | 108 | 0.160 |
Why?
| | Magnetics | 1 | 2020 | 48 | 0.160 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 15 | 0.160 |
Why?
| | Serum Albumin | 1 | 2021 | 147 | 0.160 |
Why?
| | Spirometry | 1 | 2021 | 230 | 0.160 |
Why?
| | Congresses as Topic | 2 | 2024 | 221 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 3 | 2020 | 3857 | 0.150 |
Why?
| | Biomechanical Phenomena | 5 | 2008 | 842 | 0.150 |
Why?
| | Prosthesis Implantation | 1 | 2020 | 153 | 0.140 |
Why?
| | Collagen Type II | 1 | 2019 | 54 | 0.140 |
Why?
| | Outpatients | 1 | 2022 | 439 | 0.140 |
Why?
| | Osteogenesis | 1 | 2020 | 206 | 0.140 |
Why?
| | Hemoglobins | 1 | 2021 | 383 | 0.140 |
Why?
| | Prognosis | 3 | 2016 | 4278 | 0.140 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.140 |
Why?
| | Spinal Cord Diseases | 1 | 2018 | 41 | 0.140 |
Why?
| | Respiratory Muscles | 1 | 2017 | 36 | 0.130 |
Why?
| | Absorptiometry, Photon | 2 | 2020 | 275 | 0.130 |
Why?
| | Young Adult | 8 | 2024 | 13990 | 0.130 |
Why?
| | Fractures, Bone | 1 | 2002 | 414 | 0.130 |
Why?
| | Severity of Illness Index | 3 | 2020 | 2917 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2021 | 704 | 0.130 |
Why?
| | Lower Extremity | 1 | 2021 | 438 | 0.120 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 195 | 0.120 |
Why?
| | Transition to Adult Care | 1 | 2018 | 94 | 0.120 |
Why?
| | Ireland | 1 | 2016 | 32 | 0.120 |
Why?
| | Range of Motion, Articular | 3 | 2015 | 421 | 0.120 |
Why?
| | Hypoxia | 1 | 2024 | 1199 | 0.120 |
Why?
| | Mucopolysaccharidosis VII | 1 | 2016 | 1 | 0.120 |
Why?
| | Thoracic Wall | 1 | 2016 | 21 | 0.120 |
Why?
| | Glycosaminoglycans | 1 | 2016 | 74 | 0.120 |
Why?
| | Syndrome | 3 | 2024 | 380 | 0.120 |
Why?
| | Buttocks | 1 | 2015 | 14 | 0.110 |
Why?
| | Cohort Studies | 4 | 2024 | 5935 | 0.110 |
Why?
| | Muscle Strength | 1 | 2017 | 330 | 0.110 |
Why?
| | Multimodal Imaging | 1 | 2015 | 124 | 0.110 |
Why?
| | Injections, Intramuscular | 1 | 2015 | 141 | 0.110 |
Why?
| | Fractures, Spontaneous | 1 | 2014 | 15 | 0.100 |
Why?
| | Injections, Intravenous | 1 | 2014 | 200 | 0.100 |
Why?
| | United States | 4 | 2022 | 15876 | 0.100 |
Why?
| | Thoracoscopy | 2 | 2005 | 62 | 0.100 |
Why?
| | Musculoskeletal System | 1 | 2014 | 49 | 0.100 |
Why?
| | Child Development | 1 | 2018 | 484 | 0.100 |
Why?
| | Atlanto-Axial Joint | 1 | 2013 | 12 | 0.100 |
Why?
| | Reference Values | 1 | 2014 | 797 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2018 | 592 | 0.090 |
Why?
| | Registries | 2 | 2020 | 2382 | 0.090 |
Why?
| | Physical Examination | 1 | 2013 | 236 | 0.090 |
Why?
| | Disease Progression | 2 | 2020 | 2840 | 0.090 |
Why?
| | Dysostoses | 1 | 2011 | 1 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2424 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 742 | 0.090 |
Why?
| | Operating Rooms | 2 | 2024 | 146 | 0.090 |
Why?
| | Growth Disorders | 1 | 2011 | 86 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 780 | 0.080 |
Why?
| | Delphi Technique | 2 | 2023 | 329 | 0.080 |
Why?
| | Washington | 1 | 2011 | 146 | 0.080 |
Why?
| | Prospective Studies | 5 | 2025 | 7970 | 0.080 |
Why?
| | Feasibility Studies | 3 | 2011 | 1087 | 0.080 |
Why?
| | Body Height | 2 | 2022 | 202 | 0.080 |
Why?
| | Prosthesis-Related Infections | 1 | 2011 | 99 | 0.080 |
Why?
| | Braces | 1 | 2010 | 25 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1487 | 0.080 |
Why?
| | Age Factors | 2 | 2020 | 3313 | 0.070 |
Why?
| | Laminectomy | 1 | 2009 | 31 | 0.070 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2009 | 21 | 0.070 |
Why?
| | Motor Activity | 1 | 2014 | 720 | 0.070 |
Why?
| | Cadaver | 2 | 2008 | 304 | 0.070 |
Why?
| | Surgical Procedures, Operative | 1 | 2011 | 268 | 0.070 |
Why?
| | Gait Disorders, Neurologic | 1 | 2009 | 45 | 0.070 |
Why?
| | Acetabulum | 1 | 2010 | 111 | 0.070 |
Why?
| | Arthrodesis | 1 | 2008 | 35 | 0.070 |
Why?
| | Cattle | 3 | 2005 | 999 | 0.070 |
Why?
| | Respiratory Function Tests | 2 | 2020 | 546 | 0.070 |
Why?
| | Risk Factors | 3 | 2020 | 10699 | 0.070 |
Why?
| | Decompression, Surgical | 1 | 2009 | 115 | 0.070 |
Why?
| | Hip Joint | 1 | 2009 | 172 | 0.070 |
Why?
| | Models, Animal | 2 | 2005 | 392 | 0.060 |
Why?
| | Time Factors | 2 | 2011 | 7155 | 0.060 |
Why?
| | Movement | 1 | 2008 | 293 | 0.060 |
Why?
| | Pediatrics | 1 | 2014 | 1112 | 0.060 |
Why?
| | Muscle, Skeletal | 3 | 2015 | 1792 | 0.060 |
Why?
| | Tensile Strength | 1 | 2006 | 96 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2021 | 2025 | 0.060 |
Why?
| | Ultrasonography | 1 | 2010 | 768 | 0.060 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2005 | 75 | 0.060 |
Why?
| | Bone Transplantation | 1 | 2005 | 85 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2025 | 423 | 0.050 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2024 | 14 | 0.050 |
Why?
| | Incidence | 1 | 2011 | 2870 | 0.050 |
Why?
| | Drug Carriers | 1 | 2005 | 130 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2111 | 0.050 |
Why?
| | Knee Injuries | 1 | 2005 | 122 | 0.050 |
Why?
| | Bone Nails | 1 | 2003 | 62 | 0.050 |
Why?
| | Bone Plates | 1 | 2003 | 80 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2005 | 286 | 0.050 |
Why?
| | Gait | 3 | 2015 | 313 | 0.050 |
Why?
| | Prevalence | 2 | 2020 | 2815 | 0.050 |
Why?
| | Anterior Compartment Syndrome | 1 | 2002 | 4 | 0.050 |
Why?
| | Collagen | 1 | 2005 | 455 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2002 | 36 | 0.050 |
Why?
| | Anterior Cruciate Ligament | 1 | 2003 | 101 | 0.050 |
Why?
| | Spinal Cord | 1 | 2005 | 380 | 0.050 |
Why?
| | Body Weight | 2 | 2003 | 976 | 0.040 |
Why?
| | California | 1 | 2003 | 469 | 0.040 |
Why?
| | Trauma, Nervous System | 1 | 2021 | 3 | 0.040 |
Why?
| | Posture | 1 | 2002 | 196 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2005 | 435 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 488 | 0.040 |
Why?
| | Injection Site Reaction | 1 | 2020 | 3 | 0.040 |
Why?
| | Collagen Type X | 1 | 2020 | 14 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 326 | 0.040 |
Why?
| | Women's Health | 1 | 2003 | 308 | 0.040 |
Why?
| | Exostoses | 1 | 2020 | 1 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2020 | 164 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2005 | 467 | 0.040 |
Why?
| | School Health Services | 1 | 2003 | 224 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2003 | 428 | 0.040 |
Why?
| | Exercise Test | 1 | 2003 | 634 | 0.040 |
Why?
| | Unnecessary Procedures | 1 | 2020 | 53 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2021 | 202 | 0.040 |
Why?
| | Pain Management | 1 | 2023 | 405 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 353 | 0.040 |
Why?
| | Aged | 4 | 2024 | 25850 | 0.030 |
Why?
| | Thoracotomy | 1 | 2018 | 83 | 0.030 |
Why?
| | Maximal Respiratory Pressures | 1 | 2017 | 1 | 0.030 |
Why?
| | Motivation | 1 | 2022 | 605 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5813 | 0.030 |
Why?
| | Internal Fixators | 2 | 2008 | 32 | 0.030 |
Why?
| | Sex Factors | 1 | 2003 | 2096 | 0.030 |
Why?
| | Bone Density | 1 | 2020 | 482 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 940 | 0.030 |
Why?
| | Lysosomal Storage Diseases | 1 | 2016 | 5 | 0.030 |
Why?
| | Glucuronidase | 1 | 2016 | 25 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 175 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2024 | 8243 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 487 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2016 | 311 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 476 | 0.030 |
Why?
| | Observer Variation | 1 | 2016 | 354 | 0.030 |
Why?
| | Communication | 1 | 2021 | 961 | 0.030 |
Why?
| | Middle Aged | 3 | 2024 | 35762 | 0.030 |
Why?
| | Atrophy | 1 | 2015 | 200 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 898 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2015 | 192 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1484 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 379 | 0.020 |
Why?
| | Intraoperative Complications | 2 | 2005 | 155 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3592 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 677 | 0.020 |
Why?
| | Analysis of Variance | 2 | 2005 | 1304 | 0.020 |
Why?
| | Diagnostic Techniques, Neurological | 1 | 2009 | 11 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2420 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4254 | 0.020 |
Why?
| | Pseudarthrosis | 1 | 2008 | 14 | 0.020 |
Why?
| | Animals | 3 | 2005 | 38030 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2008 | 84 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3403 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3157 | 0.020 |
Why?
| | Weight-Bearing | 1 | 2008 | 181 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 7180 | 0.010 |
Why?
| | Spinal Diseases | 1 | 2005 | 50 | 0.010 |
Why?
| | Menisci, Tibial | 1 | 2005 | 78 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 427 | 0.010 |
Why?
| | Video Recording | 1 | 2005 | 211 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2005 | 527 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2005 | 494 | 0.010 |
Why?
| | Diskectomy | 1 | 2002 | 24 | 0.010 |
Why?
| | Contraindications | 1 | 2002 | 91 | 0.010 |
Why?
| | Blood Loss, Surgical | 1 | 2002 | 112 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 2002 | 142 | 0.010 |
Why?
| | Probability | 1 | 2002 | 308 | 0.010 |
Why?
| | Primary Prevention | 1 | 2002 | 219 | 0.010 |
Why?
| | Leg | 1 | 2002 | 239 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 2002 | 512 | 0.010 |
Why?
| | Anesthesia | 1 | 2002 | 257 | 0.010 |
Why?
|
|
White's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|